Investigating the impact of genetic variation on ER stress response and disease
研究遗传变异对内质网应激反应和疾病的影响
基本信息
- 批准号:10229453
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AreaCell DeathCellsComplexDevelopmentDiabetes MellitusDiseaseDisease OutcomeDrosophila genusEndoplasmic ReticulumGenesGeneticGenetic TranscriptionGenetic VariationGoalsIndividualLaboratoriesLeftModificationMusMutationNatureNeurodegenerative DisordersOrganellesOutcomePathogenicityPathway interactionsPharmacologyPhenotypePlayProteinsRare DiseasesRoleTestingVariantbiological adaptation to stresscausal variantdesigndisease-causing mutationendoplasmic reticulum stressgenetic architecturegenetic elementgenetic variantgenome-wideindividual patientmisfolded proteinpersonalized medicineresponsetool
项目摘要
PROJECT SUMMARY
One of the biggest challenges to treating disease is the fact that individuals carrying the same
pathogenic mutation can present with different disease outcomes. It is increasingly recognized
that this variation can arise, in large part, due to genetic background differences of each individual.
In some cases, this genetic variation appears to be more important than the underlying causative
mutation. In order to truly understand how genetic variation interacts with disease causing
mutations, laboratory disease studies need to take into account genetic variation. We are applying
this approach to the endoplasmic reticulum (ER) stress response. The ER is a large organelle
responsible for the synthesis, maturation, and delivery of proteins responsible for a variety of
essential functions. ER stress occurs when misfolded proteins accumulate in the lumen of the
ER. If left unresolved, cell death occurs, followed by disease. The cell responds to ER stress with
the unfolded protein response (UPR). The UPR initiates a very large transcriptional response that
is aimed at clearing misfolded proteins from the ER. ER stress is an important component to a
number of common and rare diseases, including diabetes and neurodegenerative disorders.
Importantly, many studies are now showing that pharmacological or genetic modification of the
ER stress response can alter the outcome of many diseases. We hypothesize that genetic
variation in the ER stress response is an important contributor to variability in disease. In order to
test this, we need to understand the nature and mechanism by which ER stress varies among
individuals. We utilize a number of tools in mouse and Drosophila to understand the role of genetic
variation. We have recently demonstrated that the ER stress response and outcomes of disease
of the ER stress response are incredibly variable and complex across individuals and genetic
backgrounds. Our long term goal is to understand how genes and genetic variants interact to
produce such a variable response. To do this, we will focus on two areas in this proposal: 1)
Uncover the genetic architecture underlying genetic variation of the ER stress response in the
mouse. We propose a number of studies aimed at understanding this at the genome-wide level,
gene level, and SNP level; and 2) understand how genetic modifiers influence the phenotypic
outcome of diseases of the ER stress response. Knowing how genetic variation impacts a critical
disease-relevant pathway, like ER stress, will assist in designing personalized therapies that
might better treat the individual patient.
项目总结
治疗疾病的最大挑战之一是携带相同病毒的人
致病突变可能会导致不同的疾病结果。越来越多的人认识到
这种变异在很大程度上是由于每个人的遗传背景差异造成的。
在某些情况下,这种遗传变异似乎比潜在的病因更重要。
突变。为了真正了解基因变异如何与致病因素相互作用
突变,实验室疾病研究需要考虑到遗传变异。我们正在申请
这种方法可以应对内质网(ER)的应激反应。内质网是一个很大的细胞器
负责蛋白质的合成、成熟和传递,负责各种
基本功能。当错误折叠的蛋白质在内腔中积累时,就会发生内质网应激
呃。如果不加以解决,就会发生细胞死亡,随后就会发生疾病。细胞对内质网应激的反应是
未折叠蛋白反应(UPR)。UPR启动了一个非常大的转录反应,
旨在从内质网中清除错误折叠的蛋白质。ER压力是一个重要的组成部分
一些常见病和罕见病,包括糖尿病和神经退行性疾病。
重要的是,许多研究现在表明,药物或基因改造
内质网应激反应可以改变许多疾病的结局。我们假设基因
内质网应激反应的变化是疾病可变性的重要因素。为了
测试这一点,我们需要了解内质网应激在不同国家之间的性质和机制
个人。我们在小鼠和果蝇身上使用了许多工具来了解基因的作用
变种。我们最近证明了内质网应激反应和疾病的结局
内质网应激反应在不同的个体和基因之间是令人难以置信的可变和复杂的
背景。我们的长期目标是了解基因和基因变异如何相互作用
产生这样一种可变的反应。为此,我们将在本提案中重点关注两个方面:1)
揭示内质网应激反应遗传变异背后的遗传结构
老鼠。我们提出了一些研究,目的是在全基因组水平上理解这一点,
基因水平和SNP水平;以及2)了解遗传修饰物如何影响表型
内质网应激反应的疾病结局。了解基因变异如何影响一个关键的
与疾病相关的途径,如内质网应激,将有助于设计个性化的治疗方法
可能会更好地治疗个别病人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Clement Chow其他文献
Clement Chow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Clement Chow', 18)}}的其他基金
Investigating the impact of genetic variation on the ER stress response, protein folding, and disease
研究遗传变异对内质网应激反应、蛋白质折叠和疾病的影响
- 批准号:
10406494 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
Investigating the impact of genetic variation on ER stress response and disease
研究遗传变异对内质网应激反应和疾病的影响
- 批准号:
9381654 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
Investigating the impact of genetic variation on the ER stress response, protein folding, and disease
研究遗传变异对内质网应激反应、蛋白质折叠和疾病的影响
- 批准号:
10669737 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
Genetic Analysis of Male x Female Interaction in Drosophila Sperm Competition
果蝇精子竞争中雄性与雌性相互作用的遗传分析
- 批准号:
8175478 - 财政年份:2010
- 资助金额:
$ 38.13万 - 项目类别:
Genetic Analysis of Male x Female Interaction in Drosophila Sperm Competition
果蝇精子竞争中雄性与雌性相互作用的遗传分析
- 批准号:
7912462 - 财政年份:2010
- 资助金额:
$ 38.13万 - 项目类别:
相似国自然基金
炎性反应中巨噬细胞激活诱导死亡(activation-induced cell death,AICD)的机理研究
- 批准号:30330260
- 批准年份:2003
- 资助金额:105.0 万元
- 项目类别:重点项目
相似海外基金
Mechanism and biological significance of cell death of test cells for follicular maturation test cells
卵泡成熟试验细胞的细胞死亡机制及生物学意义
- 批准号:
23K05837 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells
人类 T 细胞再刺激诱导的细胞死亡 (RICD) 的时间和代谢调节
- 批准号:
10582089 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
The roles of cell death and mechanical signaling in aging intestinal stem cells
细胞死亡和机械信号在衰老肠道干细胞中的作用
- 批准号:
10371731 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
了解和操纵程序性细胞死亡 (PCD) 途径以促进 CAR T 细胞杀死淋巴肿瘤
- 批准号:
10326860 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Increased resistance of cells treated with exogenous sulfene sulfur donor to ferroptotic cell death
用外源亚磺基硫供体处理的细胞对铁死亡细胞的抵抗力增强
- 批准号:
21K11719 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells
人类 T 细胞再刺激诱导的细胞死亡 (RICD) 的时间和代谢调节
- 批准号:
10318993 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Molecular analysis of cell death independent function of necroptosis mediator MLKL in liver cancer cells.
肝癌细胞中坏死性凋亡介质 MLKL 的细胞死亡独立功能的分子分析。
- 批准号:
21K07115 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machanistic analysis of Ca2+ elevation before the terminal differentiation (cell death) of cutaneous epithelial cells
皮肤上皮细胞终末分化(细胞死亡)前Ca2+升高的机制分析
- 批准号:
21K16226 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells
人类 T 细胞再刺激诱导的细胞死亡 (RICD) 的时间和代谢调节
- 批准号:
10536656 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
了解和操纵程序性细胞死亡 (PCD) 途径以促进 CAR T 细胞杀死淋巴肿瘤
- 批准号:
10540403 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别: